Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Development of fibrin derivatives for controlled release of heparin-binding growth factors.
Enrollment Barriers for Molecular Targeted Trials.
Evolutionary dynamics of taxonomic structure.
Patients' Perceptions on Surgical Care Suspension for Pelvic Floor Disorders During the COVID-19 Pandemic.
Roy, Melissa
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of fibrin derivatives for controlled release of heparin-binding growth factors.
Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release. 2000 Apr 03; 65(3):389-402.
View in:
PubMed
subject areas
Algorithms
alpha-2-Antiplasmin
Animals
Anticoagulants
Antifibrinolytic Agents
Cells, Cultured
Chick Embryo
Coagulants
Cross-Linking Reagents
Delayed-Action Preparations
Drug Delivery Systems
Excipients
Fibrin
Fibroblast Growth Factor 1
Fibroblast Growth Factor 2
Heparin
Kinetics
Models, Theoretical
Neurons
Protein Binding
Transglutaminases
authors with profiles
Jeffrey Hubbell